Gene Expression Signatures for Prognosis in NSCLC, Coupled with Signatures of Oncogenic Pathway Deregulation, Provide a Novel Approach for Selection of.
David H. Harpole, Jr., M.D. Professor of Surgery Duke University Medical Center
